Difference between revisions of "Category:GnRH agonists"
Jump to navigation
Jump to search
m |
m |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | Gonadotropin-releasing hormone agonists, generally used for antineoplastic effect in hormone-dependent cancers, e.g. [[prostate cancer]] and [[breast cancer]]. | + | Gonadotropin-releasing hormone agonists, generally used for antineoplastic effect in hormone-dependent cancers, e.g. [[prostate cancer]] and [[breast cancer]]. Also sometimes referred to as leutenizing hormone-releasing hormone (LHRH) agonists. |
| − | [[Category:Endocrine therapy]] | + | [[Category:Endocrine therapeutic]] |
| + | [[Category:Androgen-deprivation therapy]] | ||
Latest revision as of 15:40, 17 May 2024
Gonadotropin-releasing hormone agonists, generally used for antineoplastic effect in hormone-dependent cancers, e.g. prostate cancer and breast cancer. Also sometimes referred to as leutenizing hormone-releasing hormone (LHRH) agonists.
Pages in category "GnRH agonists"
The following 4 pages are in this category, out of 4 total.